MolNFT v2 · #193523 · protein
7RWF: Crystal structure of CDK2 in complex with TW8672
7RWF · Cyclin-dependent kinase 2: “Crystal structure of CDK2 in complex with TW8672”. X-ray diffraction at 1.5, 1 ligand (7TW), 2 pockets (best druggability 0.78). MolNFT v2 #193523 on GenesisL1: 3D structure, binding sites and pockets in…

- PDB
- 7RWF
- Type
- protein
- Length
- 299 residues
- Chains
- 1
- Method
- x-ray diffraction
- Authors
- Sun, L., Schonbrunn, E.
- Deposited
- 08/19/21
- Collection
- MolNFT v2 / PDB Bank
- Contract
- 0xd58B01f6C18086e5202cdC5D7Ad3E41790360102
- Owner
- 0xF4e1AA6f26B7DA48EeAD9B24a97927303eeA07b8
- Resolution
- 1.5
- Source
- Homo sapiens
- Molecule
- Cyclin-dependent kinase 2
- EC
- 2.7.11.22
- UniProt
- P24941
- Ligands
- 7TW
- Pockets
- 2 · best druggability 0.78
Structure
x-ray diffraction · resolution 1.5 · 1 distinct chain · 33% helix, 16% strand (DSSP).
| Chain | Molecule | Type | Residues | Secondary structure | UniProt |
|---|---|---|---|---|---|
| A | Cyclin-dependent kinase 2 (EC 2.7.11.22) | protein | 299 | 33% helix, 16% strand | P24941 |
Ligands and binding sites
- 7TW · 2-{[2-(1H-indol-3-yl)ethyl]amino}-5-nitrobenzoic acid · ligand · chains A
- EDO · 1,2-ethanediol · additive · chains A
Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.
Pockets
2 pockets found on a 1 Å grid, 1 with a druggability of 0.5 or more.
| Volume (ų) | Druggability | Buriedness | Lining residues | Inside | |
|---|---|---|---|---|---|
| 1 | 513 | 0.78 | 0.85 | 60 | 7TW |
| 2 | 57 | 0.27 | 0.73 | 14 | empty |
Compared structures
Analyse
- Open in the research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides and crosslinks on the 3D structure
- Every structure of UniProt P24941
- Elsewhere: RCSB PDB 7RWF · PDBe 7RWF · UniProt P24941
Other records of 7RWF
- 7RWF-2 · MolNFT v1 / PDB · Crystal structure of CDK2 in complex with TW8672
GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.